The body’s defences against coronavirus
An enzyme produced by the human body is the receptor for coronavirus, but its intravenous infusion could have a positive influence on the course of Covid-19 infections, thereby serving as a new treatment option. A research group led by the Viennese physicians Manfred Hecking and Roman Reindl-Schwaighofer has now presented evidence that the body reacts to severe cases of the disease by increasing the concentration of this enzyme. These findings have now been published in the American Journal of Respiratory and Critical Care Medicine and are important news for a recently completed clinical trial.
Continue reading “The body’s defences against coronavirus”